News

Catalyst intends to investigate the reasons for the disparity between the trial results and previously published clinical and non-clinical results evaluating vigabatrin as a treatment for cocaine addiction.

According to IMS Health, Mylan has currently 117 ANDAs pending FDA approval, representing $82.1 billion in annual brand sales. Moreover, IMS also said that 35 of these pending

BIBW 2992 is a novel tyrosine kinase inhibitor that acts by irreversibly blocking the EGFR /HER2 receptors, which are promoters of tumour growth. BIBW 2992 has demonstrated preclinical

CHMP has recommended the approval of Afinitor based on data demonstrating that (when compared with placebo) Afinitor more than doubled the time without tumor growth or death in

This is a quantum leap forward in terms of accuracy with timeframes that were previously unimaginable, says Sophie Wetherall, Varian BrachyTherapy software product manager. BrachyVision Acuros offers an

The primary endpoint of this study was clinical benefit, defined as response rate (RECIST), and progression-free survival (PFS) in RCC patients. Ron Bentsur, CEO of Keryx, said: We

This follows the notification to AstraZeneca by the Netherlands Health Authority (MEB), acting as the Reference Member State for the Mutual Recognition Process (MRP), that the Seroquel XR

Under the terms of the restructured deal, BioMarin has acquired full ownership of the DMD program, including the preclinical candidate, SMT C1100. BioMarin has assumed all future preclinical

Following the positive report by CHMP, Lilly has also filed for approval of ‘pemetrexed’ in the same indication with the FDA. In the European Union and US, pemetrexed